by Seamus Bruner, Breitbart:
Earlier this month, I revealed that one of Bill Gates’s most powerful business partners, JPMorgan Chase, had reached a combined $365 million settlement with Jeffrey Epstein’s victims and the U.S. Virgin Islands, which a federal judge approved on November 9.
My new book Controligarchs: Exposing the Billionaire Class, Their Secret Deals, and the Globalist Plot to Dominate Your Life digs deeper into Gates’s partnership with JPMorgan and how it led to Gates’s relationship with Epstein via a top JPMorgan executive named James E. “Jes” Staley.
TRUTH LIVES on at https://sgtreport.tv/
In this photograph obtained by the New York Times of a gathering at Jeffrey Epstein’s Manhattan mansion in 2011, the following individuals are seen (from left to right): James E. Staley, who was a senior JPMorgan executive in 2011; former Treasury Secretary Lawrence Summers; Jeffrey Epstein; Microsoft Co-founder Bill Gates; and Boris Nikolic, who was a science adviser for the Bill and Melinda Gates Foundation. (New York Times)
Over time, Gates and JPMorgan established an investment fund that sought to profit from the development of vaccines and other health technologies. Epstein wanted a piece of the action, and Staley brought Epstein into the Gates partnership.
The Gates-JPMorgan partnership was called the Global Health Investment Fund (GHIF) and was created circa 2011. At the time, Staley managed the Epstein relationship for the bank, and Epstein was a valuable client who brought JPMorgan a lot of business. Epstein was an adviser to billionaires like Victoria’s Secret mogul Leslie Wexner and Wall Street legend Leon Black and the “family offices” which manage their fortunes. Wexner and Black deny any involvement in Epstein’s criminal activities.
James “Jes” Staley is interviewed on Bloomberg Television during the World Economic Forum (WEF) in Davos, Switzerland, on Jan. 25, 2018. (Simon Dawson/Bloomberg via Getty Images)
The GHIF partnership brought in a host of other powerful investors, including The Pfizer Foundation, Merck, GlaxoSmithKline, as well as entities funded by the governments of Sweden, Canada, and Germany. There would also be private support from “qualified individuals and family offices.”
The GHIF’s purpose was to give “individual and institutional investors the opportunity to finance late-stage global health technologies that have the potential to save millions of lives in low-income countries.” The Bill & Melinda Gates Foundation and the Swedish International Development Cooperation Agency committed to help offset any potential GHIF losses.
